Your browser doesn't support javascript.
loading
Cold-Adapted Viral Attenuation (CAVA): Highly Temperature Sensitive Polioviruses as Novel Vaccine Strains for a Next Generation Inactivated Poliovirus Vaccine.
Sanders, Barbara P; de Los Rios Oakes, Isabel; van Hoek, Vladimir; Bockstal, Viki; Kamphuis, Tobias; Uil, Taco G; Song, Yutong; Cooper, Gillian; Crawt, Laura E; Martín, Javier; Zahn, Roland; Lewis, John; Wimmer, Eckard; Custers, Jerome H H V; Schuitemaker, Hanneke; Cello, Jeronimo; Edo-Matas, Diana.
Afiliação
  • Sanders BP; Janssen Infectious Diseases and Vaccines, Pharmaceutical Companies of Johnson and Johnson, Leiden, the Netherlands.
  • de Los Rios Oakes I; Janssen Infectious Diseases and Vaccines, Pharmaceutical Companies of Johnson and Johnson, Leiden, the Netherlands.
  • van Hoek V; Janssen Infectious Diseases and Vaccines, Pharmaceutical Companies of Johnson and Johnson, Leiden, the Netherlands.
  • Bockstal V; Janssen Infectious Diseases and Vaccines, Pharmaceutical Companies of Johnson and Johnson, Leiden, the Netherlands.
  • Kamphuis T; Janssen Infectious Diseases and Vaccines, Pharmaceutical Companies of Johnson and Johnson, Leiden, the Netherlands.
  • Uil TG; Janssen Infectious Diseases and Vaccines, Pharmaceutical Companies of Johnson and Johnson, Leiden, the Netherlands.
  • Song Y; Department of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, New York, United States of America.
  • Cooper G; Division of Virology, National Institute for Biological Standards and Control, Potters Bar, United Kingdom.
  • Crawt LE; Division of Virology, National Institute for Biological Standards and Control, Potters Bar, United Kingdom.
  • Martín J; Division of Virology, National Institute for Biological Standards and Control, Potters Bar, United Kingdom.
  • Zahn R; Janssen Infectious Diseases and Vaccines, Pharmaceutical Companies of Johnson and Johnson, Leiden, the Netherlands.
  • Lewis J; Janssen Infectious Diseases and Vaccines, Pharmaceutical Companies of Johnson and Johnson, Leiden, the Netherlands.
  • Wimmer E; Department of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, New York, United States of America.
  • Custers JH; Janssen Infectious Diseases and Vaccines, Pharmaceutical Companies of Johnson and Johnson, Leiden, the Netherlands.
  • Schuitemaker H; Janssen Infectious Diseases and Vaccines, Pharmaceutical Companies of Johnson and Johnson, Leiden, the Netherlands.
  • Cello J; Department of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, New York, United States of America.
  • Edo-Matas D; Janssen Infectious Diseases and Vaccines, Pharmaceutical Companies of Johnson and Johnson, Leiden, the Netherlands.
PLoS Pathog ; 12(3): e1005483, 2016 Mar.
Article em En | MEDLINE | ID: mdl-27032093
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Poliomielite / Vacina Antipólio de Vírus Inativado / Poliovirus Tipo de estudo: Diagnostic_studies Limite: Animals Idioma: En Revista: PLoS Pathog Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Poliomielite / Vacina Antipólio de Vírus Inativado / Poliovirus Tipo de estudo: Diagnostic_studies Limite: Animals Idioma: En Revista: PLoS Pathog Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Holanda